ArticleFrontiers in cardiovascular medicine2026

Effect of rosuvastatin and ezetimibe therapy on LDL-cholesterol reduction and non-invasive arterial injury markers in children with heterozygous familial hypercholesterolemia: a prospective, open-label, randomized study.

Ajda Skarlovnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.